Nageshwar Budha - Senior Scientist, Clinical Pharmacology

Nageshwar Budha

Senior Scientist, Clinical Pharmacology

"It is a great privilege to work at a company that uses cutting–edge research and focuses on developing innovative and novel therapies for diseases with unmet medical need. I’m deeply grateful for the opportunity to work with the best and brightest scientists in their respective fields."
Years at Genentech
Awards & Honors

I joined Genentech in 2009 as an Associate Scientist in the department of Clinical Pharmacology. My responsibilities include developing rational and strategic clinical pharmacology plans and providing data analysis support to ensure appropriate dose/route/schedule decisions are made for molecules in late stage clinical development. Over the years, I have got the opportunity to work with very talented scientists and supported molecules, both large and small, in multiple therapeutic areas at various stages of clinical development.

Featured Publication

Modeling and Simulation to Support Phase 2 Dose Selection for RG7652, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9.

AAPS J. 2015 Jul;17(4):881-90.

Budha NR, Leabman M, Wada R, Jin JY, Peng K, Baruch A, Tingley WG, and Davis JD.